Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | EVP, CHIEF HR OFFICER | February 28, 2025 | March 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date February 28, 2025 · Filed March 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.01 par valueSEC Table I · non-derivative | Direct | 6,130 |
Ending reported balance
After 2025-03-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-02-28 · Tax withholding · Disposed 16,904 · Balance 27,380 Row 2 · 2025-03-03 · Sale · Disposed 5,677 · Balance 21,703 F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.16 to $210, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2025-03-03 · Sale · Disposed 14,973 · Balance 6,730 F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.25 to $211.23, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2025-03-03 · Sale · Disposed 600 · Balance 6,130 F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.3 to $211.4, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.16 to $210, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.25 to $211.23, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.3 to $211.4, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2015 Filed Mar 3, 2015 23:07 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,074 | $60.51 | $125,491.52 |
DisclosureSEC source: 0001179110-15-004096 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,860 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 23:07 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 6,128 | $60.52 | $370,866.56 |
DisclosureSEC source: 0001179110-15-004096 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,934 Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:11 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 50,350 | $0.00 Strike: $58.88 | $0.00 |
DisclosureSEC source: 0001179110-15-003164 · edgar.xml · derivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,350 Underlying: Common stock · 50,350 shares Expires 2025-02-18 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 16,784 on 02/19/2016, 16,783 on 02/19/2017, and 16,783 on 02/19/2018. Read SEC document |
| February 19, 2015 Filed Feb 23, 2015 22:11 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 25,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003164 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,062 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2015 Filed Feb 19, 2015 22:51 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 241 | $58.70 | $14,146.94 |
DisclosureSEC source: 0001179110-15-002972 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,592 Read SEC document |
| February 17, 2015 Filed Feb 19, 2015 22:51 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 551 | $58.05 | $31,985.55 |
DisclosureSEC source: 0001179110-15-002972 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,833 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:14 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 6,669 | $50.91 | $339,518.79 |
DisclosureSEC source: 0001179110-14-004341 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,384 Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:20 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 51,990 | $0.00 Strike: $51.42 | $0.00 |
DisclosureSEC source: 0001179110-14-003478 · edgar.xml · derivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,990 Underlying: Common stock · 51,990 shares Expires 2024-02-19 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 17,330 on 02/20/2015, 17,330 on 02/20/2016, and 17,330 on 02/20/2017. Read SEC document |
| February 20, 2014 Filed Feb 24, 2014 22:20 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 30,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003478 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,053 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $51.24 | $10,247.00 |
DisclosureSEC source: 0001179110-14-003087 · edgar.xml · nonDerivative · entry 4 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,913 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 265 | $51.23 | $13,574.63 |
DisclosureSEC source: 0001179110-14-003087 · edgar.xml · nonDerivative · entry 3 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,113 Read SEC document |
| February 18, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 558 | $50.73 | $28,307.34 |
DisclosureSEC source: 0001179110-14-003087 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,378 Read SEC document |
| February 17, 2014 Filed Feb 19, 2014 22:35 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 534 | $50.73 | $27,089.82 |
DisclosureSEC source: 0001179110-14-003087 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,936 Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 560 | $47.78 | $26,757.36 |
DisclosureSEC source: 0001179110-14-002333 · edgar.xml · nonDerivative · entry 3 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,470 Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $47.78 | $9,556.60 |
DisclosureSEC source: 0001179110-14-002333 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,030 Read SEC document |
| February 05, 2014 Filed Feb 7, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 700 | $47.79 | $33,449.50 |
DisclosureSEC source: 0001179110-14-002333 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,230 Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 3,235 | $49.23 | $159,259.05 |
DisclosureSEC source: 0001179110-14-001873 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,930 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:03 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 464 | $37.58 | $17,437.12 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 4 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,165 Read SEC document |
| February 18, 2013 Filed Feb 20, 2013 00:03 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 496 | $37.58 | $18,639.68 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 3 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,629 Read SEC document |
| February 17, 2013 Filed Feb 20, 2013 00:03 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 534 | $37.58 | $20,067.72 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,125 Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:03 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 87,040 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · derivative · entry 5 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,040 Underlying: Common stock · 87,040 shares Expires 2023-02-13 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 29,014 on 02/14/2014, 29,013 on 02/14/2015, and 29,013 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:03 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 42,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,659 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.